Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cryoablation for Monomorphic Ventricular Tachycardia

NCT: NCT05675865 · RECRUITING

NCT IDNCT05675865
StatusRECRUITING
Start Date2023-09-11
Completion2027-03-30

Brief Summary

The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

Frequently Asked Questions

What is Cryoablation for Monomorphic Ventricular Tachycardia?

Cryoablation for Monomorphic Ventricular Tachycardia is a clinical trial registered under NCT05675865. Current status: RECRUITING.

What is the status of NCT05675865?

The current status of NCT05675865 (Cryoablation for Monomorphic Ventricular Tachycardia) is: RECRUITING.

When did Cryoablation for Monomorphic Ventricular Tachycardia start?

Cryoablation for Monomorphic Ventricular Tachycardia started on 2023-09-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑